• Home
  • 2.0 LPBI Executive Summary
  • 1.0 LPBI Executive Summary
  • Journal PharmaceuticalIntelligence.com
  • Portfolio of IP Assets
  • Knowledge PORTALS System (KPS)
  • 1.0 LPBI – 2012-2020 VISTA
  • LPBI Group’s History
  • 2.0 LPBI – 2021-2025 VISION
  • BioMed e-Series
  • Press Coverage
  • Investor Relations
  • Our TEAM
  • Founder
  • Funding, Deals & Partnerships
  • 1.0 LPBI Group News
  • 1.0 LPBI CALENDAR
  • 2.0 LPBI Group News
  • Testimonials about LPBI
  • DrugDiscovery @LPBI Group
  • Medical 3D Printing
  • e-VOICES Podcasting
  • LPBI Newsletters
  • Customer Surveys
  • Health Care INVESTOR’s Corner ($)
  • 2021 Summer Internship Portal
  • 2021-2022 Medical Text Analysis (NLP)
  • Artificial Intelligence: Genomics & Cancer
  • SOP Web STAT
  • Blockchain Transactions Network Ecosystem
  • Contact Us
  • 1.0 LPBI Brochure
  • 2.0 LPBI Brochure
  • 2.0 LPBI – Calendar of Zooms
  • Coronavirus, SARS-CoV-2 Portal
  • LPBI India
  • Synthetic Biology in Drug Discovery
  • Certificate One Year
  • NFT: Redefined Format of IP Assets
  • Audio English-Spanish: BioMed e-Series
  • Five Bilingual BioMed e-Series
  • Press Releases
  • Intangibles CIM

Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Funding, Deals & Partnerships: BIOLOGICS & MEDICAL DEVICES; BioMed e-Series; Medicine and Life Sciences Scientific Journal – http://PharmaceuticalIntelligence.com

Feeds:
Posts
Comments

Customer Surveys

Customer Surveys

 

December 2019: Survey #1:

Readership Survey for Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Designed by Gail Thornton, PhD(c) 

 

 

We would appreciate your participation in our survey, which will help us improve our ability to communicate medical and scientific content.

 

Please email the results of this survey to: AvivaLev-Ari@alum.berkeley.edu

 

  1. How do you generally get information about scientific and medical information and/or disease conditions?

 

Choose all that apply:

 

□ LPBI Group website

□ Scientific and medical web sites

□ Health reporting web sites

□ Medical trade publications

□ PubMed sites

□ Medical conferences and related web sites

□ Social media sites

□ Podcasts

□ Other _______________

 

  1. When you visit the LPBI Group web site, which sections of the web site do you read?

□ Latest medical and scientific news coverage

□ Medical conference proceedings

□ Selection of 16 e-books

 

  1. In general, do you think that the medical and scientific news coverage on the LPBI web site is too short or too long?

 

Choose one of the following answers:

 

□ Too short

□ Too long

□ Sufficient length

□ No opinion

 

  1. How frequently do you visit the LPBI Group web site?

□ 1-3 times per week

□ 1-3 times per month

□ Less than once per month

 

  1. When you read the information on the LPBI Group web site, how long are you typically on the site?

□ Less than 5 minutes

□ Less than 30 minutes

□ 60 minutes or more

 

  1. Do you take advantage of the suggested links in the articles on the LPBI Group web site for additional related articles and resources?

 

□ I click on the text links in the articles I read

□ I click on the links at the ends of articles

 

If so, do you find this information relevant?

□ Yes

□ No

 

 

  1. Please rate the quality of the LPBI Group web site, including medical and scientific news, medical conference proceedings and selection of e-books.

 

                                   Excellent   Good        Average        Poor            No Opinion
Content
Writing
Ease of reading
Stories of interest
Layout and design

 

  1. Please indicate your agreement with this statement: LPBI Group strengthens my professional connection to current medical and scientific news and noteworthy topics of interest.

□ Strongly agree

□ Agree

□ Disagree

□ Strongly disagree

□ No Opinion

 

  1. Please suggest overall comments about the value of the LPBI Group offerings (i.e., medical and scientific news coverage, medical conference proceedings, selection of e-books).

 

_____________________________________________________________________

 

_____________________________________________________________________

 

  1. Please suggest overall comments about improvements to the LPBI Group web site.

 

______________________________________________________________________

 

______________________________________________________________________

 

 

  1. What do you like most about the LPBI Group web site?

 

______________________________________________________________________

 

______________________________________________________________________­­­­­­­­­

  1. What do you like least about the LPBI Group web site?

 

______________________________________________________________________

 

______________________________________________________________________

 

  1. How did you arrive at this survey?

□ Found it on the LPBI Group web site

□ Found it on social media

□ Found it advertised in the LPBI Group web site

□ Word of mouth / a friend told me

□ LPBI email as I am a follower of this blog

□ Other (please specify)

 

  1. Any suggestions for ways we can improve the LPBI Group web site, its medical and scientific news coverage, its medical conference coverage and selection of e-books?

 

______________________________________________________________________

 

______________________________________________________________________

 

 

 

Thank you for participating in our survey.

 

Please visit our LPBI Group of offerings:

 

  • For the LPBI Journal:

https://pharmaceuticalintelligence.com/

  • For the BioMed e-Series:

https://lnkd.in/ekWGNqA

  • For 70 Conference e-Proceedings:

https://pharmaceuticalintelligence.com/press-coverage/part-three-conference-eproceedings-deliverables-social-media-analytics/

 

###

 

 

 

 

Share this:

  • Click to share on Twitter (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to print (Opens in new window)
  • Click to email a link to a friend (Opens in new window)

Like this:

Like Loading...

  • Follow Blog via Email

    Enter your email address to follow this blog and receive notifications of new posts by email.

    Join 9,459 other subscribers
  • Recent Posts

    • Creating a Twitter Space for @pharma_BI for Live Broadcasts March 14, 2023
    • The Vibrant Philly Biotech Scene: Recent Happenings & Deals March 11, 2023
    • Peak oxygen uptake (VO2peak) quantified fitness: Lifelong and late-onset athletes had higher VO2peak than non-athletes March 7, 2023
    • Merck’s sotatercept overachieves, PCSK9 inhibitor passes phase 2 March 6, 2023
    • Bacterial multidrug resistance problem solved by a broad-spectrum synthetic antibiotic March 1, 2023
    • Genetic variation causes human lupus, systemic lupus erythematosus (SLE) February 23, 2023
    • Mimicking vaginal cells and microbiome interactions on chip microfluidic culture February 14, 2023
    • Press Release for Five Bilingual BioMed e-Series in English and in Spanish January 29, 2023
    • 2022 FDA Drug Approval List, 2022 Biological Approvals and Approved Cellular and Gene Therapy Products January 17, 2023
    • Verily announced other organizational changes, 1/13/2023 January 16, 2023
  • Archives

  • Categories

  • Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    • 1 2012pharmaceutical
    • 1 Amandeep Kaur
    • 1 Aashir Awan, Phd
    • 1 Abhisar Anand
    • 1 Adina Hazan
    • 1 Alan F. Kaul, PharmD., MS, MBA, FCCP
    • 1 alexcrystal6
    • 1 anamikasarkar
    • 1 apreconasia
    • 1 aviralvatsa
    • 1 David Orchard-Webb, PhD
    • 1 danutdaagmailcom
    • 1 Demet Sag, Ph.D., CRA, GCP
    • 1 Dror Nir
    • 1 dsmolyar
    • 1 Ethan Coomber
    • 1 evelinacohn
    • 1 Gail S Thornton
    • 1 Irina Robu
    • 1 jayzmit48
    • 1 jdpmd
    • 1 jshertok
    • 1 kellyperlman
    • 1 Ed Kislauskis
    • 1 larryhbern
    • 1 Madison Davis
    • 1 marzankhan
    • 1 megbaker58
    • 1 ofermar2020
    • 1 Dr. Pati
    • 1 pkandala
    • 1 ritusaxena
    • 1 Rick Mandahl
    • 1 sjwilliamspa
    • 1 Srinivas Sriram
    • 1 stuartlpbi
    • 1 Dr. Sudipta Saha
    • 1 tildabarliya
    • 1 vaishnavee24
    • 1 zraviv06
    • 1 zs22

Powered by WordPress.com.

WPThemes.


%d bloggers like this: